Self-injectable contraceptives could be life-saver in Africa, health experts say

Self-injectable contraceptives, that are being trialed in Uganda and Senegal, could change women’s lives in farming Africa and dramatically cut maternal and baby deaths, health experts pronounced on Tuesday.

The disposable $1 device consists of a tiny needle connected to a cosmetic burble containing a preventive Depo-Provera that can be squeezed to inject a sip that lasts 3 months.

Self-injectables could have a vital impact on a lives of women who can't entrance clinics or who face antithesis to preventive use from their partners, pronounced a tellurian health classification PATH that has designed a device called Sayana Press.

“This is a life-saver. This is a game-changer for family planning,” PATH’s Emmanuel Mugisha told a Thomson Reuters Foundation during Women Deliver, a world’s biggest women’s health and rights discussion in a decade.

More on this…

About a third of maternal deaths could be avoided by loitering motherhood, spacing births, preventing unintended pregnancies, and avoiding vulnerable abortions, according to PATH.

Unwanted pregnancies also cut brief girls’ preparation and stop them reaching their potential.

Mugisha, PATH’s Uganda director, pronounced women in farming areas could spend an whole day movement to a hospital and queuing for contraceptives usually to learn they were out of stock.

“In Africa, one of a hindrances with family formulation is access. The second interruption is us men,” he said.

“Most group don’t wish family planning. Some wish some-more children, though others consider it interferes with their sex life.

“With Sayana Press a lady has a leisure to confirm when she wants children and when she doesn’t, and a male will have no control; a male will not know, that is unequivocally good.”

Mugisha pronounced self-injectable contraceptives would also revoke a high numbers of women failing during botched abortions in Uganda.


Some 225 million women in building countries have an unmet need for family planning, according to U.N. data.

If this need were met, unintended pregnancies would tumble by 70 percent, vulnerable abortions by 74 percent, maternal deaths by 25 percent and baby deaths by 18 percent.

Trials with Sayana Press, that is made by Pfizer, are being carried out to safeguard women can remember to take it, discharge it rightly and dispose of a device safely so that it does not get picked adult by children.

Nomi Fuchs-Montgomery, an consultant on preventive record during a Bill and Melinda Gates Foundation that is assisting support a trials, pronounced early indications were unequivocally positive.

“We see so most guarantee with this,” she added. “This is unequivocally a future.”

Fuchs-Montgomery pronounced augmenting a accessibility of contraception had a vital purpose to play in assembly many of a Sustainable Developing Goals – a U.N. goals concluded final year for finale inequality and impassioned poverty.

Access to contraception allows women to finish their education, follow careers and attend economically that has “an implausible knock-on effect” on their wider communities and inhabitant development, she added.

PATH is also conducting trials in Burkina Faso and Niger where village health workers are regulating a device to broach contraceptives to women.

Some 5,500 representatives from over 160 countries – including process makers, business leaders, health workers, activists and celebrities – are attending a Women Deliver discussion that ends on Thursday.

You must be logged in to post a comment Login

Widgetized Section

Go to Admin » appearance » Widgets » and move a widget into Advertise Widget Zone